The document announces an upcoming anti-counterfeiting conference titled "Pharma Security World 2018". It lists several prominent speakers from pharmaceutical companies and organizations that will be joining the conference to discuss challenges in combating counterfeit medicines. The conference will focus on strategies to protect brands and build genuine supply chains, and will provide opportunities for partnerships to encourage collaboration against counterfeiting. Key areas to be covered include tackling counterfeiting through public-private initiatives, securing supply chain integrity, and developing sustainable serialization strategies.
Authentication Solutions are a must to curb spurious medicines
There are a variety of solutions available, as per requirement, through member companies of ASPA. The Government of India has already taken steps to protect medicines that are exported. Now it is time to protect medicines that are being distributed and consumed within India.
4th annual Pharma Anti-Counterfeiting 2015Dinesh T
4th Annual Pharma Anti-Counterfeiting 2015 taking place on 08th & 09th September 2015, London, UK
Please contact me :-Dinesh:- dinesh@virtueinsight.co.in
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Just to remind you that registrations for our 18th Pharmacovigilance 2019 event, which is taking place at The Pestana Chelsea Bridge Hotel in London, UK on 27-28th Feb are closing soon.For more details email to dinesh@virtueinsightsummits.com
Everyone involved in the goods supply chain - manufacturers, distributors, consumers, taxation and
government authorities- has learnt the value of security holograms and will be reassured by their presence
on products and/or the packaging, recognising the benefits they provide. However, as coding and serialisation becomes mandated in various countries for products such
as medicines and tobacco products, the ability to incorporate QR, data matrix and other types of code in to
holograms further enhances the role they can play in supply chain control. Ian Lancaster, general secretary
of the International Hologram Manufacturers Association, highlights the latest developments.
Drug counterfeiting is a significant public health threat and is rapidly increasing with dozens of new cases being reported throughout the world every day. In the past few months, various
news has been reported in media referring the ongoing activities of counterfeiters making fake and sub-standard medicines in
different parts of India. The article is on need of anti-counterfeit secured packaging solutions like tamper evident and serialization.
This document provides an agenda and details for the "Anti-Counterfeiting Pharma 2015" conference taking place on March 11-12, 2015 in London. The conference will feature presentations and panel discussions on topics related to anti-counterfeiting strategies in the pharmaceutical industry, including serialisation, supply chain security, legislation, mobile technologies, and tackling online pharmaceutical crime. Prominent speakers will represent organizations such as Sanofi, Shire Pharmaceuticals, MHRA, GS1, and Arnold & Porter LLP. Attendees will include professionals from R&D, supply chain, packaging, and other relevant roles within the pharmaceutical industry.
Authentication Solutions are a must to curb spurious medicines
There are a variety of solutions available, as per requirement, through member companies of ASPA. The Government of India has already taken steps to protect medicines that are exported. Now it is time to protect medicines that are being distributed and consumed within India.
4th annual Pharma Anti-Counterfeiting 2015Dinesh T
4th Annual Pharma Anti-Counterfeiting 2015 taking place on 08th & 09th September 2015, London, UK
Please contact me :-Dinesh:- dinesh@virtueinsight.co.in
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Just to remind you that registrations for our 18th Pharmacovigilance 2019 event, which is taking place at The Pestana Chelsea Bridge Hotel in London, UK on 27-28th Feb are closing soon.For more details email to dinesh@virtueinsightsummits.com
Everyone involved in the goods supply chain - manufacturers, distributors, consumers, taxation and
government authorities- has learnt the value of security holograms and will be reassured by their presence
on products and/or the packaging, recognising the benefits they provide. However, as coding and serialisation becomes mandated in various countries for products such
as medicines and tobacco products, the ability to incorporate QR, data matrix and other types of code in to
holograms further enhances the role they can play in supply chain control. Ian Lancaster, general secretary
of the International Hologram Manufacturers Association, highlights the latest developments.
Drug counterfeiting is a significant public health threat and is rapidly increasing with dozens of new cases being reported throughout the world every day. In the past few months, various
news has been reported in media referring the ongoing activities of counterfeiters making fake and sub-standard medicines in
different parts of India. The article is on need of anti-counterfeit secured packaging solutions like tamper evident and serialization.
This document provides an agenda and details for the "Anti-Counterfeiting Pharma 2015" conference taking place on March 11-12, 2015 in London. The conference will feature presentations and panel discussions on topics related to anti-counterfeiting strategies in the pharmaceutical industry, including serialisation, supply chain security, legislation, mobile technologies, and tackling online pharmaceutical crime. Prominent speakers will represent organizations such as Sanofi, Shire Pharmaceuticals, MHRA, GS1, and Arnold & Porter LLP. Attendees will include professionals from R&D, supply chain, packaging, and other relevant roles within the pharmaceutical industry.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
This document advertises an international conference on implementing the IDMP standards for pharmaceutical data. The conference will be held in Berlin in June 2015 and will provide opportunities to:
1) Learn how to assess data requirements and analyze interpretations of the IDMP standards from experts;
2) Benchmark your organization's IDMP implementation process with peers from large and mid-size pharmaceutical companies; and
3) Share insights on how the IDMP standards are changing interactions between IT systems, company functions, and regulatory agencies.
Interactive workshops and case studies from major pharmaceutical companies will also be provided. The conference aims to help companies understand, prioritize, and implement strategies to achieve seamless and fully compliant regulatory information management under the new ID
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
3rd corporate compliance & transparency in pharmaMarket iT
This document summarizes a conference on corporate compliance and transparency in the pharmaceutical industry to be held in Zurich, Switzerland on February 25-26, 2015. The conference will address topics such as EFPIA disclosure requirements, defining transparency frameworks, preventing corruption, and challenges in emerging markets. It will feature speakers from pharmaceutical companies and industry groups. Attendees will include compliance officers, lawyers, and those involved in corporate responsibility, contracts, auditing, and business conduct.
The document is an invitation to the "Anti-Counterfeiting Americas" conference on November 8-9, 2010 in Boston. The conference will provide insights into issues related to securing the pharmaceutical supply chain and tracking technologies. Key topics will include tackling counterfeit drugs, improving distribution integrity, and collaboration against counterfeiting. Attendees will gain an understanding of supply chain challenges and investment potential in pharmaceutical logistics. The conference will feature speakers from organizations focused on supply chain security and counterfeit drug prevention.
Infection Surveillance Solutions Market PPT: Growth, Outlook, Demand, Keyplay...IMARC Group
The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032.
More Info:- https://www.imarcgroup.com/infection-surveillance-solutions-market
Product tracking and tracing with Blockchain and Internet of ThingsMurali Venkatesh
Infosys and Oracle published a white paper regarding our Blockchain and IoT solution
URL: https://www.infosys.com/Oracle/insights/Documents/product-tracking-tracing.pdf
This document provides a summary of a report on global traceability and serialization in the pharmaceutical industry. It discusses the results of a survey on pharmaceutical serialization and traceability in 2014. The main challenges for manufacturers in implementing serialization included cost, integration with existing systems, generating high-speed printing of unique codes, and inconsistent regulations across countries. Regulations like the EU Falsified Medicines Directive and the US Drug Supply Chain Security Act are aiming to improve security and tracking of pharmaceuticals in the supply chain. Overall, the report examines the progress of serialization efforts and the ongoing challenges faced by the industry.
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Digital technologies like 3D printing, blockchain, and robotics are disrupting the traditionally regulated life sciences sector. This transformation brings new compliance risks around issues like:
- Partnerships with companies from other sectors that may not understand life sciences compliance
- Use of data from wearables and how it will be protected and used ethically
- Interactions with regulators to approve innovative, non-traditional products like those using artificial intelligence
- Power of informed patients who want treatments based on measurable outcomes
The high level of sector regulation remains, but methods of improper practices may change. Ongoing monitoring of issues like interactions with healthcare professionals and reliance on third parties will still be needed to mitigate corruption risks in this disrupted environment
The document proposes a blockchain-based drug supply chain supervision system to address issues like counterfeiting by allowing all stakeholders like suppliers, manufacturers, transporters, wholesalers, distributors and pharmacies to trace drugs from origin to consumer through an immutable record of transactions. Key components of the proposed system include smart contracts, a Goerli test network and tools like Truffle, Metamask, Solidity and Web3.js to develop a decentralized application that can track drugs and authenticate participants in the supply chain.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
Philadelphia Dropping The Gavel On Counterfeit DrugsChris Miller
The document discusses issues around counterfeit drugs and strategies for addressing them through product serialization and codification. It notes the large and growing problem of counterfeit drugs, outlines regulatory pressures in Europe and the US to implement serialization, and discusses benefits serialization can provide to businesses including improved supply chain management, authentication of products, and protection of brand integrity.
Development Standards and Regulations for HealthTechElinext
Wearables, surgery robots, wellness platforms, and digital doctors. The new healthcare landscape is bright, full of novelties and breaking ideas. But before entering this market, you should learn the basic regulations and standards for HealthTech products. We gathered all the information for you in our new infographic.
This document summarizes an upcoming conference on anti-counterfeiting in the pharmaceutical industry with the following key details:
- The conference will take place at the Strand Palace Hotel in London and feature over 30 speakers from major pharmaceutical companies, technical solution providers, and regulatory organizations.
- Topics to be discussed over the two day event include serialization and traceability challenges, authentication technologies, supply chain security strategies, global regulatory landscapes, and raising public awareness of counterfeit medicines.
- Attendees from last year's event commented that the conference brought the industry closer to understanding the global health problems caused by counterfeiting and provided informative insights from pharmaceutical companies and organizations.
The document provides information about the 9th Pharmacovigilance Conference to be held on September 2nd, 2015 in Mumbai, India. It discusses key themes that will be covered including legislation, audits, signal detection, patient safety, and the developing regulatory framework. It outlines the agenda with topics such as PV for biologics, challenges in PV lifecycle management, and the necessary shift of sponsors and CROs from adversaries to partners. The conference aims to bring together representatives from the pharmaceutical industry and regulatory bodies to address issues in pharmacovigilance and risk management. It is intended to help attendees expand their knowledge and network with industry leaders.
Dear Reader,
Welcome to the 26th edition of our newsletter “The Authentication Times”.
Various Government authorities across the globe consider drug counterfeiting to be a major issue and coming with various policy measures in order to fight against this menace. The Indian Government has also mandated for all pharmaceutical firms to build track and trace capability for exports using barcode technology at three levels of packaging: primary, secondary and tertiary. Although the Government is doing work at the policy level, there is a clear need to involve all stakeholders in the efforts in fighting this menace.
The mandates to serialize all pharmaceutical products is a challenge for pharmaceutical manufacturers. Keeping in view, we decided to cover a story highlighting “Overview on Pharmaceutical Serialisation”. The issue also covers our series of article on “Authentication Technologies”. The current article will give an overview of key available anti-counterfeiting technologies to be followed by anti-tamper technology and track and trace technologies. Apart from this the issue also covers the industry updates including news, counterfeit seizure report, appointment, global patents and upcoming events.
Do send us your feedback/critics at info@aspaglobal.com.
With Best Regards,
C S Jeena
Editor
The Kenya Pharmaceutical Regulatory Compliance Conference – July 25 – 26, 2017 at the Radisson Blu Hotel, Nairobi.
Compliance in the pharmaceutical industry is a critical issue, particularly in Kenya. Pharmaceutical companies across the globe face unparalleled challenges in the dynamically changing clinical, regulatory and business landscape. As regulatory scrutiny of the Pharmaceutical industry continues to intensify, compliance teams face increasingly complex challenges related to Legal Frameworks and Compliance, Effective Third Party Compliance Strategies, Best Practice Compliance Strategies, Internal Controls and Risk Management, Complexities of HCP interactions.
The inaugural edition of the Kenya Pharmaceutical Regulatory Compliance Conference will provide a venue for industry experts, policymakers, manufacturers, distributors, retailers and inventors to discuss and debate the challenges they face as well as explore new strategies.
The document provides information about an upcoming conference on pharmaceutical regulatory compliance in Kenya.
The conference will provide a venue for industry experts, policymakers, manufacturers, distributors, retailers and inventors to discuss challenges in the dynamically changing pharmaceutical landscape and explore new strategies. It will feature presentations, panels, workshops and exhibitions.
The event aims to bring together stakeholders in the pharmaceutical industry to address issues of regulatory compliance and engage on strengthening the regulatory framework in Kenya. Non-compliance poses risks to public health and undermines industry credibility. The conference organizers hope it will facilitate industry cooperation on regulatory best practices.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
More Related Content
Similar to Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety Conference
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
This document advertises an international conference on implementing the IDMP standards for pharmaceutical data. The conference will be held in Berlin in June 2015 and will provide opportunities to:
1) Learn how to assess data requirements and analyze interpretations of the IDMP standards from experts;
2) Benchmark your organization's IDMP implementation process with peers from large and mid-size pharmaceutical companies; and
3) Share insights on how the IDMP standards are changing interactions between IT systems, company functions, and regulatory agencies.
Interactive workshops and case studies from major pharmaceutical companies will also be provided. The conference aims to help companies understand, prioritize, and implement strategies to achieve seamless and fully compliant regulatory information management under the new ID
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
3rd corporate compliance & transparency in pharmaMarket iT
This document summarizes a conference on corporate compliance and transparency in the pharmaceutical industry to be held in Zurich, Switzerland on February 25-26, 2015. The conference will address topics such as EFPIA disclosure requirements, defining transparency frameworks, preventing corruption, and challenges in emerging markets. It will feature speakers from pharmaceutical companies and industry groups. Attendees will include compliance officers, lawyers, and those involved in corporate responsibility, contracts, auditing, and business conduct.
The document is an invitation to the "Anti-Counterfeiting Americas" conference on November 8-9, 2010 in Boston. The conference will provide insights into issues related to securing the pharmaceutical supply chain and tracking technologies. Key topics will include tackling counterfeit drugs, improving distribution integrity, and collaboration against counterfeiting. Attendees will gain an understanding of supply chain challenges and investment potential in pharmaceutical logistics. The conference will feature speakers from organizations focused on supply chain security and counterfeit drug prevention.
Infection Surveillance Solutions Market PPT: Growth, Outlook, Demand, Keyplay...IMARC Group
The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032.
More Info:- https://www.imarcgroup.com/infection-surveillance-solutions-market
Product tracking and tracing with Blockchain and Internet of ThingsMurali Venkatesh
Infosys and Oracle published a white paper regarding our Blockchain and IoT solution
URL: https://www.infosys.com/Oracle/insights/Documents/product-tracking-tracing.pdf
This document provides a summary of a report on global traceability and serialization in the pharmaceutical industry. It discusses the results of a survey on pharmaceutical serialization and traceability in 2014. The main challenges for manufacturers in implementing serialization included cost, integration with existing systems, generating high-speed printing of unique codes, and inconsistent regulations across countries. Regulations like the EU Falsified Medicines Directive and the US Drug Supply Chain Security Act are aiming to improve security and tracking of pharmaceuticals in the supply chain. Overall, the report examines the progress of serialization efforts and the ongoing challenges faced by the industry.
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Digital technologies like 3D printing, blockchain, and robotics are disrupting the traditionally regulated life sciences sector. This transformation brings new compliance risks around issues like:
- Partnerships with companies from other sectors that may not understand life sciences compliance
- Use of data from wearables and how it will be protected and used ethically
- Interactions with regulators to approve innovative, non-traditional products like those using artificial intelligence
- Power of informed patients who want treatments based on measurable outcomes
The high level of sector regulation remains, but methods of improper practices may change. Ongoing monitoring of issues like interactions with healthcare professionals and reliance on third parties will still be needed to mitigate corruption risks in this disrupted environment
The document proposes a blockchain-based drug supply chain supervision system to address issues like counterfeiting by allowing all stakeholders like suppliers, manufacturers, transporters, wholesalers, distributors and pharmacies to trace drugs from origin to consumer through an immutable record of transactions. Key components of the proposed system include smart contracts, a Goerli test network and tools like Truffle, Metamask, Solidity and Web3.js to develop a decentralized application that can track drugs and authenticate participants in the supply chain.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
Philadelphia Dropping The Gavel On Counterfeit DrugsChris Miller
The document discusses issues around counterfeit drugs and strategies for addressing them through product serialization and codification. It notes the large and growing problem of counterfeit drugs, outlines regulatory pressures in Europe and the US to implement serialization, and discusses benefits serialization can provide to businesses including improved supply chain management, authentication of products, and protection of brand integrity.
Development Standards and Regulations for HealthTechElinext
Wearables, surgery robots, wellness platforms, and digital doctors. The new healthcare landscape is bright, full of novelties and breaking ideas. But before entering this market, you should learn the basic regulations and standards for HealthTech products. We gathered all the information for you in our new infographic.
This document summarizes an upcoming conference on anti-counterfeiting in the pharmaceutical industry with the following key details:
- The conference will take place at the Strand Palace Hotel in London and feature over 30 speakers from major pharmaceutical companies, technical solution providers, and regulatory organizations.
- Topics to be discussed over the two day event include serialization and traceability challenges, authentication technologies, supply chain security strategies, global regulatory landscapes, and raising public awareness of counterfeit medicines.
- Attendees from last year's event commented that the conference brought the industry closer to understanding the global health problems caused by counterfeiting and provided informative insights from pharmaceutical companies and organizations.
The document provides information about the 9th Pharmacovigilance Conference to be held on September 2nd, 2015 in Mumbai, India. It discusses key themes that will be covered including legislation, audits, signal detection, patient safety, and the developing regulatory framework. It outlines the agenda with topics such as PV for biologics, challenges in PV lifecycle management, and the necessary shift of sponsors and CROs from adversaries to partners. The conference aims to bring together representatives from the pharmaceutical industry and regulatory bodies to address issues in pharmacovigilance and risk management. It is intended to help attendees expand their knowledge and network with industry leaders.
Dear Reader,
Welcome to the 26th edition of our newsletter “The Authentication Times”.
Various Government authorities across the globe consider drug counterfeiting to be a major issue and coming with various policy measures in order to fight against this menace. The Indian Government has also mandated for all pharmaceutical firms to build track and trace capability for exports using barcode technology at three levels of packaging: primary, secondary and tertiary. Although the Government is doing work at the policy level, there is a clear need to involve all stakeholders in the efforts in fighting this menace.
The mandates to serialize all pharmaceutical products is a challenge for pharmaceutical manufacturers. Keeping in view, we decided to cover a story highlighting “Overview on Pharmaceutical Serialisation”. The issue also covers our series of article on “Authentication Technologies”. The current article will give an overview of key available anti-counterfeiting technologies to be followed by anti-tamper technology and track and trace technologies. Apart from this the issue also covers the industry updates including news, counterfeit seizure report, appointment, global patents and upcoming events.
Do send us your feedback/critics at info@aspaglobal.com.
With Best Regards,
C S Jeena
Editor
The Kenya Pharmaceutical Regulatory Compliance Conference – July 25 – 26, 2017 at the Radisson Blu Hotel, Nairobi.
Compliance in the pharmaceutical industry is a critical issue, particularly in Kenya. Pharmaceutical companies across the globe face unparalleled challenges in the dynamically changing clinical, regulatory and business landscape. As regulatory scrutiny of the Pharmaceutical industry continues to intensify, compliance teams face increasingly complex challenges related to Legal Frameworks and Compliance, Effective Third Party Compliance Strategies, Best Practice Compliance Strategies, Internal Controls and Risk Management, Complexities of HCP interactions.
The inaugural edition of the Kenya Pharmaceutical Regulatory Compliance Conference will provide a venue for industry experts, policymakers, manufacturers, distributors, retailers and inventors to discuss and debate the challenges they face as well as explore new strategies.
The document provides information about an upcoming conference on pharmaceutical regulatory compliance in Kenya.
The conference will provide a venue for industry experts, policymakers, manufacturers, distributors, retailers and inventors to discuss challenges in the dynamically changing pharmaceutical landscape and explore new strategies. It will feature presentations, panels, workshops and exhibitions.
The event aims to bring together stakeholders in the pharmaceutical industry to address issues of regulatory compliance and engage on strengthening the regulatory framework in Kenya. Non-compliance poses risks to public health and undermines industry credibility. The conference organizers hope it will facilitate industry cooperation on regulatory best practices.
Similar to Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety Conference (20)
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety Conference
1. MORE TOP SPEAKERS JOINING OUR LINE UP SOON.
OUR PROMINENT SPEAKERS
Director, Supply Operations
and GS
GIANPIERO
LORUSSO
Merck
Head of Healthcare, IoT
Vertical Market Development
GLEN
HODGSON
GS1 UK
Director Industrial Anti-counterfeiting
Strategy
JEAN MARC
BOBEE
Sanofi
External Manufacturing
Organization latam Head
LUIZ ALBERTO
BARBERINI
Bayer
Adobe eSign 21 CFR 11
Validation Test Lead
MARK
LUND-CONLON
GE Healthcare
Director, Global Security EMEA
PATRICK
HOLT
Pfizer
Executive Director
MIKE
ISLES
EAASM
Head Supply Chain
NURETTIN
EKIZOGLU
Novartis
Associate VP - Head of Digital
Supply Chain Practice, Internet of
Things and Blockchain
PATRICK
STRAUSS
Antuit
Market Development Manager
TIM
MCGARR
BSI
Forensic Lab Manager,
Authenticate Limited
Former counterfeit Lab Manager
Pfizer
WENDY
GREENALL
Head of Security Operations
TOM
COCHRANE
MundiPharma
Former Head of Threat and Intelligence Drugs
TONY
SAGGERS
National Crime Agency (NCA)
Director - Internet Infrastructure
Investigation (Former Consultant
Internet Infrastructure Manager
MHRA)
STEPHEN
TRUICK
PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018
HOLIDAY INN LONDON - KENSINGTON
LONDON, UNITED KINGDOM.
"An Anti-counterfeiting, Brand Safety Conference"CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
SPEAKER
TBA
Astrazeneca
OUR FIRST LINE UP OF
Deputy Director
IP Enforcement
Intellectual Property Office, UK
MATTHEW
COPE
Head of Global Complaint
Management Europe -
F.Hoffmann-La Roche
HUGUES
ISEL
(Chair of EU Anticounterfeiting
subcommittee (2016-17),
International Trademark
Association) - Principal
Rouse Consultancy
JEREMY
NEWMAN
WANT TO SPEAK?
please e-mail to
speaker@corvusglobalevents.com
WANT TO SPONSOR
OR EXHIBIT?
sponsor@corvusglobalevents.com
MEDIA & PARTNERSHIP
ENQUIRIES
mediapartner@corvusglobalevents.com
2. PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018, , HOLIDAY INN - KENSINGTON
LONDON, UNITED KINGDOM.
CONFERENCE FOCUS
The pharmaceutical industry has an array of duties of keeping up with technology and research as
well as the unbridled counterfeit products that can thwart the efforts. The snide, intended to mimic the
genuine products, have in many cases led to lack of effective healing, adverse reactions and now the
diminishing confidence in medicines and the general healthcare systems and the providers of the
same. With sales ranging from €150 billion to €200 billion which is US$163 billion to $217 billion every year,
as indicated by industry estimates, fake pharmaceuticals are the most lucrative segment of the
worldwide exchange illicitly replicated merchandise. World Health Organization (WHO) approximates
30 percent of drugs that reach developing nations are counterfeit and this can have substantial effects
for the brand as well as on the patients. What's more, pharmaceutical companies and regulators are
creating ways to stop them. No nations stay untouched by this issue, what was once viewed as an issue
endured by developing nations has now turned into an issue to developing nations including US and
Europe. We require both countrywide and industry-level participation, and in addition public and private
sector coordinated effort, to identify and definitively battle counterfeiters.
The US is driving the path with the Drug Supply Chain Security Act (DSCSA) approved in 2013.
DSCSA guide for end-to-end traceability is extended over a period of 10 years, with expectations
sketched through out the supply chain. In the US, lot- level traceability started in January 2015 under
the under the act with package-level serialization to be finished in November 2017. The complete
supply chain is relied upon to be electronically incorporated and all hubs of traceability to be built up
by November 2023. The E.U.’s Falsified Medicines Directive requires drug companies to adopt mass
serialization and other anti-counterfeiting measures starting in 2019. Manufacturers who operate in
the E.U. will have to add unique identification numbers to the outer packaging of all prescription
drugs, and equip containers with tamperproof seals. To guide customers from illicit online drug stores
that supply fake medications, the FMD requires approved legitimate Internet drug stores to show a
logo distinguishing them as E.U. approved drug retailers.
To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma
Security World 2018 – An Anti-counterfeiting & Brand Safety Conference, which will have
Pharma industry experts sharing various challenges faced, new strategies, case studies and use of
innovative ideas and the conference will also offer opportunities to encourage partnerships and
collaborations.
It gives us a great pleasure to welcoming you to the Pharma Security World 2018
KEY HIGHLIGHTS
Tackling pharmaceutical crime - initiatives at multinational, EU and national level
IP and regulatory enforcement
Strategies for public awareness and patient protection
Best practices to protect your brand
The role of the Internet in aiding the counterfeiters – How to overcome the situation?
The Common Logo initiative in the EU for online pharmacies
Brand Protection & Securing supply chain integrity
End to End supply chain visibility
Developing a sustainable Serialization strategy
Global enterprise level solutions for anti-counterfeiting
Integration of track & trace solutions in production and supply chain
Smart Packaging, Labeling, Artwork, Warehouse & Logistics
Effective Authentication Technologies
Best selection of tamper-evident features
Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
Measuring the Effectiveness of a Good Quality System through frequent external and internal audits
Debating the use and implementation of serialization, barcoding, and RFID
Serialization Data and Analytics driven approach to increase supply chain agility
Cloud-based technology complement big data solutions in monitoring and improving supply chain processes
The need to understand and adopt new technologies like IoT, Analytics, Block chain, AI and others
Case study: How companies are structuring their counterfeiting efforts and departments?
CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
3. GET IN TOUCH WITH THE TEAM
CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
WANT TO SPEAK?
please e-mail to
speaker@corvusglobalevents.com
WANT TO SPONSOR
OR EXHIBIT?
sponsor@corvusglobalevents.com
MEDIA & PARTNERSHIP
ENQUIRIES
mediapartner@corvusglobalevents.com
WHO SHOULD ATTEND
THE CONFERENCE
Attendees includes VPs, GMs, Directors, Heads and Managers of
Ÿ Intellectual Property, investigators and Trademark council
Ÿ Law enforcements & legal services
Ÿ Drug regulatory agencies and customs
Ÿ Pharmaceutical manufacturers and distributors
Ÿ Healthcare professionals
Ÿ Pharmacists
Ÿ Serialization, Track and Trace solution providers
Ÿ Brand protection, enforcement, security, integrity and management companies
Ÿ Healthcare research organizations
Ÿ Pharmaceutical industry professional associations
Ÿ Anti-counterfeiting organizations
Ÿ Supply Chain management companies
Ÿ Packaging, labeling and converting companies
Ÿ Authentication technology suppliers
Ÿ Contract manufacturing organization (CMOs)
Ÿ IT service providers
PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018, , HOLIDAY INN - KENSINGTON
LONDON, UNITED KINGDOM.
4. Ÿ The common Anti-counterfeiting strategies in EU, US and the
rest of the world to handle the counterfeit medicines
Ÿ Identification of countries severely affected by the counterfeit
medicines
Ÿ The challenges of combating counterfeit medicines in most
affected countries
Ÿ The loopholes in various legislations encouraging gray market
to thrive
Registration & Morning Coffee08:30
CONFERENCE SCHEDULE
TH
DAY 1 - 20 March 2018
Chairperson's opening remarks09:20
A multi-layered approach is the way to go for optimal
brand protection
09:30
Anti-counterfeiting market and challenges
PATRICK HOLT
Director, Global Security EMEA, Pfizer
Worldview of Counterfeit drugs - The evolving counterfeit
challenges
10:00
Networking and Refreshment Break10:30
Ÿ Supply and demand drivers
Ÿ Synergies between illicit drug markets and counterfeit
pharmaceuticals
Ÿ Strategic response design and delivery
Understanding illicit markets and establishing strategic
responses to disrupt the threats that supply them
10:50
Networking and Luncheon12:50
Advancement in IP enforcement in Europe and what's
next?
11:50
CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
How to better engage and assure full compliance from
external partneship using a bayer's external manufacturing's
governance model
13:30
Ÿ Intellectual property rights (IPR) laid down by the World
Intellectual Property Organisation (WIPO)
Ÿ Brexit: English Intellectual Property law implications
Is your organization ready for DSCSA, EU FMD and Other
Global Regulations?
11:20
Regulatory, Compliance and IP
Ÿ Develop a strategy protecting the patient safety, brand
reputation, intellectual property rights and revenue
Ÿ Guidelines to prevent counterfeit from entering the supply chain
Ÿ Monitoring the complex counterfeiters threatening enforcement
efforts
Ÿ Create a team which has experts from Law enforcement, supply
chain, packaging technology and legal
Ÿ Develop best practices for counterfeit detection, prevention and
deterrence
SPEAKER TBC
Integra
Ÿ Legitimate vs Illegitimate supply chain
Ÿ The rising threat of websites selling falsified medicines –
tackling the supply side
Ÿ Raising public awareness to tackle the demand side – who has
a stake?
Fighting fakes by raising public awareness14:30
Combating the rise of global online pharmacies - Are we
underestimating the threat?
15:20
Ÿ Approaches to authenticate the online pharmacy
Ÿ Will E.U.'s Falsified Medicines Directive help in controlling the
interent pharmacies?
Ÿ Improved regulation of online pharmacy market
Ÿ Educating the public on what falsified medicines are and the
risks that they pose
Ÿ Collaboration and coordination of multiple stakeholders through
out the supply chain
Ÿ A public–private partnership model
Afternoon Tea/Coffee15:00
Panel Discussion: Creating a joint anti-counterfeiting
approach - Enhancing a coherent relationship between all
stakeholders of both private and public sector
16:20
To fight against product counterfeiting, the brand owners, law
enforcement agencies, industry associations, service providers,
government agencies and others should come together sharing their
ideas and perspective
LUIZ ALBERTO BARBERINI
External Manufacturing Organization latam Head, Bayer
MIKE ISLES
Executive Director, The European Alliance for Access to Safe
Medicines (EAASM)
Ÿ How to define and successfully implement your strategy for
global regulatory compliance?
Ÿ Identyfying and Implementing the new traceability and
interoperability capabilities
Ÿ Aligning with global standards
How the Internet is used by the criminal networks what
are the current trends and what companies can do to
12:20
STEPHEN TRUICK
Director - Internet Infrastructure Investigation, Former
Consultant Internet Infrastructure Manager, MHRA
The importance of rigorous computer system validation
testing and staff training in meeting the regulatory
requirements of the EU FMD, DSCSA and other global
regulations
14:00
MARK LUND-CONLON
Adobe eSign 21 CFR 11 Validation Test Lead, GE Healthcare
PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018, , HOLIDAY INN - KENSINGTON
LONDON, UNITED KINGDOM.
TONY SAGGERS
Director of StraTac Logical Limited(Former Head of Drugs Threat
& Intelligence - National Crime Agency)
Ÿ New EU initiatives to counter growing IPR infringement and
counterfeits
Ÿ Reducing Intellectual Property Crime through Effective
Partnerships
Case Study: How Roche manages confirmed counterfeit
cases at a worldwide level. From the information about a
counterfeit case to the answer given to Health Authorities
15:50
HUGUES ISEL
Head of Global Complaint Management Europe
F.Hoffmann-La Roche
5. Ÿ Entry level to high-end security features – What level of security
do we want to build in our packaging design?
Ÿ Bespoke components into a label
Ÿ Overt, covert or forensic solutions
Ÿ Anti-tamper and brand protection features
Strategies to improve efficiencies in Artwork & labeling to
implementation
14:30
Networking Lucheon12:50
The rising demand for Anti-counterfeit packaging – An
increase in the trade among developed and developing
countries
13:30
CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
Chairperson's closing remarks16:50
Networking Drinks Session17:00
Registration & Morning Coffee08:30
Chairperson's opening remarks09:20
st
DAY 2 - 21 MARCH 2018
Ÿ How are these different traceability concepts are impacting
the stakeholders of the pharma supply chain ?
Ÿ What are their pros and cons and how efficient are they to
protect patients from counterfeits, considering their
implementation efforts and especially their « Security to
Cost" ratio ?
Ÿ What are the traceability challenges stil to be overcome in
the next 5 years ?
Ÿ Why do we need harmonization of serialization controls
strategy in order to maximize patient protection ?
How Serialization Controls Strategy impact Stakeholders of
the Supply Chain and Patient Protection. Comparison of
different pharmatraceabilty concepts
09:30
JEAN MARC BOBEE
Director Industrial Anti-counterfeiting Strategy, Sanofi
Supply Chain, Serialization and Track & Trace
Improving supply chain visibility and Eliminating Blind Spots10:00
NURETTIN EKIZOGLU
Head Supply Chain, Novartis
Networking and Refreshment Break10:30
Networking and Refreshment Break15:00
Ÿ Minimising the risk using a risk minimisation plan
Ÿ Data driven approach to your supply chain risk management
Ÿ Responsive and demand driven supply chain
Developing a Risk Management Plan for your supply chain
to protect your Brand, Product and Patient Safety
15:30
Ÿ How will the future technologies be used in the pharmaceutical
industry: IoT, Analytics, Blockchain, AI and others?
Ÿ Product identification and traceability solutions which can adapt to
market changes and comply with serialization regulations in
different countries
Ÿ Building an interconnectivity across the supply chain
Ÿ Planning and executing a sustainable strategy for the cost-
effective implementation and driving ROI
Panel discussion: Scalable and future-proof system to
battle counterfeiting
16:00
PATRICK STRAUSS, Associate VP - Head of Digital Supply Chain
Practice, Internet of Things and Blockchain, Antuit
WENDY GREENALL
Forensic Laboratory Manage, Autenticate Limited. Former
Counterfeit Lab Manager, Pfizer
Ÿ What needs to be done to collaborate at all levels –
Regional, National and International
Ÿ Harmonizing the legal framework for anti-counterfeiting and
anti-piracy
Ÿ How are Interpol, Europol and the United Nations Office of
Drugs and Crime are fighting against counterfeiting?
Ÿ Role of the international organizations (WHO, WIPO, WTO
etc.) in preventing the counterfeit medicines entry into the
world markets
Ÿ Standards as a tool to prevent counterfeiting
Ÿ Regulatory bodies taking action
Ÿ Authentication or traceability – Europe & the world
standards – a critical tool in the fight against counterfeiting10:50
GLEN HODGSON
Head of Healthcare, IoT Vertical Market Development, GS1 UK
Ÿ Stock based model to real time model
Ÿ Monitoring transportation and warehousing activities
Ÿ Big data solutions that support integrated business planning
Ÿ Cloud-based technology complement big data solutions in
monitoring and improving supply chain processes
Ÿ How digitization makes the supply chain more agile, efficient
and customer-focused?
Serialization Data and Analytics driven approach to increase
supply chain agility - A digital approach to the supply chain
11:20
Optimizing Traceability and Tracking to combat
counterfeiting
11:50
Packaging & Labelling and Next Gen Anti-Counterfeiting
New automated warehouse installation and integration
of logistic with packaging environment at manufacturing
level
14:00
GIANPIERO LORUSSO
Director, Supply Operations and GS, Merck
TIM MCGARR
Market Development Manager (DIgital) BSI
Ÿ How to effectively manage your supply chain?
Ÿ Bespoke Business Models based on the current trends
Ÿ Providing access to real-time information
Ÿ Using IT to overcome the blindspots
Ÿ Establishing a cross functional team
Ÿ How will the pharmaceutical industry be benifited from traceability?
Ÿ A Long term Cost-Effective Serialisation And Traceability Strategies
Ÿ Benefits Beyond Serialization and Traceability Compliance
Security in the supply chain protecting your shipments
against diversion ,temperature excursion, anti-bribery
and corruption and customer authentication etc
12:20
TOM COCHRANE
Head of Security Operations, Mundipharma
JEREMY NEWMAN
Principal, Rouse Consultancy (Chair of EU Anticounterfeiting
subcommittee (2016-17), International Trademark Association
(INTA)
Ÿ Current trends in the packaging market and strategies adopted
by key players
Ÿ Ensuring the packages comply with the new regulations and
standards
Ÿ Support from contract service providers, suppliers and others
Ÿ Contract Packaging Market Trends
Mobile platform as a unique global technology tool15:30
Chairperson's closing remarks and end of conference16:50
PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018, , HOLIDAY INN - KENSINGTON
LONDON, UNITED KINGDOM.
SPEAKER TBC
AstraZeneca
6. DELEGATE REGISTRATION FORM
Pass Types :
Team Discounts
Total No of Delegate
Price
Price
Price
st
Super Early Bird Pass Options ( Until Oct 31 )
st
Early Bird Pass Options ( Until Dec 31 )
th
Standard Pass Options ( Until Mar19 )
Collateral Pack in Delegate Tote Bag
Super Early Bird Single
Early Bird Single
Standard Pass Single
Super Early Bird Group ( 3 for 2 )
Early Bird Group ( 3 for 2 )
Standard Pass Group ( 3 for 2 )
£ 530 + VAT
£ 699 + VAT
£ 950 + VAT
£ 1060 + VAT
£ 1398 + VAT
£ 1900 + VAT
£ 750 + VAT
Bring your team and get an extra discount. There are special group packages available.
Please email to delegate@corvusglobalevents.com for more details.
For Registering more than 1 delegate kindly send the details of all the
delegates through email with the copy of this registration form
For Registration or more infomation on the Program please call at +44 (0) 207 096 0786 Email : info@corvusglobalevents.com
Visa Master American Express Invoice me
Expiry Date :
Payment Options :
Check : ( Make checks payable to the Corvus Global Events )
Card Type :
Security No :
Card Holder Name :
Card Holder Signature :
Billing Address :
Card Number :
Invoice Details :
Name :
Comapany Name :
Address :
City :
State :
Email :
Mobile :
Zip Code :
Country :
Delegate Details :
Name :
Comapany Name :
Jop Tittle :
Address :
Mobile No :
Email id :
TERMS & CONDITIONS PAYMENT
Payment Terms
All bookings made prior to the conference must be paid in full to guarantee registration. Payment can be made through booking via credit card, debit card, bank transfer or cheque
payment. Once payment has been received, an email confirmation and a receipted invoice will be sent. If payment is not made at the time of booking, registration will be
provisional. If you apply to register for the conference less than two (2) weeks before the date of the conference we will only accept payment by a credit card, unless we expressly
agree otherwise in writing.
Cancellation or Substitution Policy
Substitutions are allowed with the written permission of the original registrant up to 48 hours prior to the start of the event, at no extra charge.
Should substitution not be possible, cancellation can be done subject to an administrative fee.
CORVUS
www.corvusglobalevents.com info@corvusglobalevents.com +44 (0) 207 096 0786
Bank Details :
Account Name : CORVUS GLOBAL EVENTS LIMITED
Account Number : 21370568
Bank Name : Lloyds BANK
Sort Code : 30-96-26
SWIFT/BIC Code : LOYDGB21446
IBAN : GB64LOYD30962621370568
PHARMA SECURITY
WORLD 2018
TH ST
20 AND 21 MARCH 2018, , HOLIDAY INN - KENSINGTON
LONDON, UNITED KINGDOM.